|
GMO ALTERNATIVE ALLOCATION FUND
|
| |
Summary Prospectus
June 30, 2022 |
|
|
Share Class:
|
| |
Class I
|
| |
Class R6
|
|
|
Ticker:
|
| |
GAAGX
|
| |
GAAKX
|
|
| | |
Class R6
|
| |
Class I
|
| ||||||
Management fee
|
| | | | 0.95%1 | | | | | | 0.95%1 | | |
Total other expenses
|
| | | | 0.73% | | | | | | 0.81%4 | | |
Dividend and interest expense on short sales
|
| | | | 0.58%2 | | | | | | 0.50%2 | | |
All other expenses
|
| | | | 0.15% | | | | | | 0.31%4 | | |
Acquired fund fees and expenses (underlying fund expenses)
|
| | | | 0.03%3 | | | | | | 0.03%3 | | |
Total annual fund operating expenses
|
| | | | 1.71% | | | | | | 1.79% | | |
Expense reimbursement/waiver
|
| | | | (0.13%)1 | | | | | | (0.19%)1,4 | | |
Total annual fund operating expenses after expense reimbursement/waiver
(Fund and underlying fund expenses) |
| | | | 1.58% | | | | | | 1.60% | | |
| | |
1 Year
|
| |
3 Years
|
| |
5 Years
|
| |
10 Years
|
| ||||||||||||||||
Class R6 | | | | $ | 161 | | | | | | $ | 526 | | | | | | $ | 916 | | | | | | $ | 2,009 | | | |
Class I | | | | $ | 163 | | | | | | $ | 545 | | | | | | $ | 952 | | | | | | $ | 2,090 | | | |
| | | | | |
1 Year
|
| | |
5 Years
|
| | |
10 Years
|
| | |
Incept.
|
| | ||||||||||||||||
| | Class VI | | | | | | | | | | | | | | | | | | | | | | | | | | | |
5/1/19
|
| | ||||
| |
Return Before Taxes
|
| | | | | -5.12 | % | | | | | | | N/A | | | | | | | | N/A | | | | | | | | -1.05 | % | | | |
| |
Return After Taxes on Distributions
|
| | | | | -6.30 | % | | | | | | | N/A | | | | | | | | N/A | | | | | | | | -2.21 | % | | | |
| |
Return After Taxes on Distributions and
Sale of Fund Shares |
| | | | | -2.69 | % | | | | | | | N/A | | | | | | | | N/A | | | | | | | | -1.16 | % | | | |
| |
FTSE 3-Month Treasury Bill Index
(returns reflect no deduction for fees or expenses, but are net of withholding tax on dividend reinvestments) |
| | | | | 0.05 | % | | | | | | | N/A | | | | | | | | N/A | | | | | | | | 0.77 | % | | | |
| | Class I | | | | | | | | | | | | | | | | | | | | | | | | | | | |
9/4/19
|
| | ||||
| |
Return Before Taxes
|
| | | | | -5.39 | % | | | | | | | N/A | | | | | | | | N/A | | | | | | | | -1.83 | % | | | |
| |
FTSE 3-Month Treasury Bill Index
(returns reflect no deduction for fees or expenses, but are net of withholding tax on dividend reinvestments) |
| | | | | 0.05 | % | | | | | | | N/A | | | | | | | | N/A | | | | | | | | 0.53 | % | | | |
Investment Team
|
| |
Senior Member (Length of Service with Fund)
|
| |
Title
|
|
Asset Allocation | | | Ben Inker (since the Fund’s inception in 2019) | | | Co-Head, Asset Allocation Team, GMO. | |
Asset Allocation | | | John Thorndike (since October 2021) | | | Co-Head, Asset Allocation Team, GMO. | |
Asset Allocation | | | B.J. Brannan (since the Fund’s inception in 2019) | | | Portfolio Manager, Asset Allocation Team, GMO. | |
Asset Allocation | | | Matt Kadnar (since the Fund’s inception in 2019) | | | Portfolio Manager, Asset Allocation Team, GMO. | |